Newron Pharmaceuticals to present three posters on evenamide in treatment-resistant schizophrenia at ECNP Congress 2025
Newron Pharmaceuticals announced that it will present three posters at the upcoming 38th Congress of the European College of Neuropsychopharmacology taking place in Amsterdam, the Netherlands, from October 11… read more.
